United States
Germany
Japan
United Kingdom
China
Lenti ORF clone of Human transforming growth factor, beta 2 (TGFB2), transcript variant 1, mGFP tagged
| Type | Human Tagged ORF Clone |
| Tag | mGFP |
| Vector | pLenti-C-mGFP-P2A-Puro |
- LentiORF®
Products
Lenti ORF clone of Human transforming growth factor, beta 2 (TGFB2), transcript variant 1, Myc-DDK-tagged
| Type | Human Tagged ORF Clone |
| Tag | Myc-DDK |
| Vector | pLenti-C-Myc-DDK |
- LentiORF®
Lenti ORF clone of Human transforming growth factor, beta 2 (TGFB2), transcript variant 2, Myc-DDK-tagged
| Type | Human Tagged ORF Clone |
| Tag | Myc-DDK |
| Vector | pLenti-C-Myc-DDK |
- LentiORF®
Lenti ORF clone of Human transforming growth factor, beta 2 (TGFB2), transcript variant 2, mGFP tagged
| Type | Human Tagged ORF Clone |
| Tag | mGFP |
| Vector | pLenti-C-mGFP-P2A-Puro |
- LentiORF®
Lenti ORF clone of Human transforming growth factor, beta 2 (TGFB2), transcript variant 1, mGFP tagged
| Type | Human Tagged ORF Clone |
| Tag | mGFP |
| Vector | pLenti-C-mGFP |
- LentiORF®
Lenti ORF clone of Human transforming growth factor, beta 2 (TGFB2), transcript variant 1, Myc-DDK-tagged
| Type | Human Tagged ORF Clone |
| Tag | Myc-DDK |
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
- LentiORF®
Lenti ORF clone of Human transforming growth factor, beta 2 (TGFB2), transcript variant 2, mGFP tagged
| Type | Human Tagged ORF Clone |
| Tag | mGFP |
| Vector | pLenti-C-mGFP |
- LentiORF®
Lenti ORF clone of Human transforming growth factor, beta 2 (TGFB2), transcript variant 2, Myc-DDK-tagged
| Type | Human Tagged ORF Clone |
| Tag | Myc-DDK |
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
- LentiORF®
活动过滤器
优化搜索结果
Category
Species
Tags
Vectors
Mutants
Brands
Pathways
- Cell cycle (8)
- Chronic myeloid leukemia (8)
- Colorectal cancer (8)
- Cytokine-cytokine receptor interaction (8)
- Dilated cardiomyopathy (8)
- Hypertrophic cardiomyopathy (HCM) (8)
- MAPK signaling pathway (8)
- Pancreatic cancer (8)
- Pathways in cancer (8)
- Renal cell carcinoma (8)
- TGF-beta signaling pathway (8)
